retatrutide women results Experimental drug shows promising in trial What is Retatrutide (Triple G)?
Description
Before starting GLP-1 injections , patients should undergo a professional medical evaluation to review their health history, medications, weight-loss goals, and potential risk factors
Depending on the patient's profile, this review may occur asynchronously or may involve a video consultation
In other words, the headline is simple
The 124,001 participants without a history of substance abuse who were taking GLP-1 drugs had 14% lower odds of developing a new substance use disorder over the following three years than the 400,816 similar patients prescribed SGLT-2 inhibitors
